RAF1 and central nervous system cancer: Beyond B-RAF, C-RAF and A-RAF mutations are rare but can be found in lung, ovarian, pancreatic, and glioma cancers, often presenting challenges due to RAF dimerization and limited therapeutic options [16,17].